The data reported by Fukushima et al. [27] suggested Connexin 43 as a tumor suppressor gene and transfection of Connexin 43 cDNA into human prostate cancer PC-3 cells increased tumor cell sensitivity to Docetaxel. This evidence concerns the gene GJA1 and neoplasm.